Sleepnet Revenue and Competitors
Estimated Revenue & Valuation
- Sleepnet's estimated annual revenue is currently $13.4M per year.
- Sleepnet's estimated revenue per employee is $243,000
Employee Data
- Sleepnet has 55 Employees.
- Sleepnet grew their employee count by 2% last year.
Sleepnet's People
Name | Title | Email/Phone |
---|
Sleepnet Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5.3M | 28 | -10% | N/A | N/A |
#2 | $18.2M | 75 | 1% | N/A | N/A |
#3 | $390.1M | 1032 | 4% | N/A | N/A |
#4 | $162.7M | 482 | N/A | N/A | N/A |
#5 | $792.3M | 2096 | 3% | N/A | N/A |
#6 | $78.1M | 263 | 8% | N/A | N/A |
#7 | $7.3M | 34 | 10% | N/A | N/A |
#8 | $523.5M | 1385 | 8% | N/A | N/A |
#9 | $69.8M | 235 | 5% | N/A | N/A |
#10 | $160.3M | 475 | 21% | N/A | N/A |
What Is Sleepnet?
Sleepnet® Corporation is a privately-owned Hampton, New Hampshire based designer and manufacturer of AIR◦gel™ masks for the sleep-disordered breathing (SDB) and acute care product industry across more than 40 countries worldwide For more than fifteen years, Sleepnet has manufactured high-quality gel masks used in the treatment of Obstructive Sleep Apnea (OSA) and non-invasive ventilation. Sleepnet offers high-quality masks such as Mojo®, Aura, iQ® and Phantom® for SDB patients and MiniMe® 2, MiniMe® and VeraSeal 2™ for the pediatric and disposable non-invasive ventilation mask markets respectively. Sleepnet manufactures private label masks for multinational respiratory product distributors. Sleepnet is ISO 13485 certified and its products are FDA cleared and CE marked. Learn more about Sleepnet at http://www.SleepnetMasks.com.
keywords:N/AN/A
Total Funding
55
Number of Employees
$13.4M
Revenue (est)
2%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $3.5M | 56 | 33% | N/A |
#2 | $11.1M | 56 | -8% | N/A |
#3 | $12.6M | 57 | -2% | N/A |
#4 | $12.6M | 57 | 2% | N/A |
#5 | $7.5M | 59 | -8% | N/A |